Subject to Completion
Preliminary Term Sheet dated
May 26, 2023
|
Filed Pursuant to Rule 433
Registration Statement No. 333-259205 (To Prospectus dated September 14, 2021, Prospectus Supplement dated September 14, 2021
and Product Supplement EQUITY ARN-1 dated
November 29, 2021)
|
Units
$10 principal amount per unit
CUSIP No.
|
Pricing Date*
Settlement Date*
Maturity Date*
|
June , 2023
June , 2023
August , 2024
|
|||
![]() |
*Subject to change based on the actual date the notes are priced for initial sale to the public (the “pricing date”)
|
||||
Accelerated Return Notes® Linked to the SPDR®
Gold Shares
◾
Maturity of approximately 14 months
◾
3-to-1 upside exposure to increases in the SPDR® Gold Shares (the “Market Measure”), subject to a capped return of [15.25% to 19.25%]
◾
1-to-1 downside exposure to decreases in the Market Measure, with 100% of your principal at risk
◾
All payments occur at maturity and are subject to the credit risk of Royal Bank of Canada
◾
No periodic interest payments
◾
In addition to the underwriting discount set forth below, the notes include a hedging-related charge of $0.05 per unit. See “Structuring the Notes”
◾
Limited secondary market liquidity, with no exchange listing
◾
The notes are unsecured debt securities and are not savings accounts or insured deposits of a bank. The notes are not insured or guaranteed by the Canada Deposit
Insurance Corporation, the U.S. Federal Deposit Insurance Corporation, or any other governmental agency of Canada or the United States
|
|||||
Per Unit
|
Total
|
|
Public offering price(1)
|
$10.000
|
$
|
Underwriting discount(1)
|
$0.175
|
$
|
Proceeds, before expenses, to RBC
|
$9.825
|
$
|
(1) |
For any purchase of 300,000 units or more in a single transaction by an individual investor or in combined transactions with the investor's household in this offering, the public offering price and the underwriting discount will be
$9.950 per unit and $0.125 per unit, respectively. See “Supplement to the Plan of Distribution” below.
|
Are Not FDIC Insured
|
Are Not Bank Guaranteed
|
May Lose Value
|
Issuer:
|
Royal Bank of Canada (“RBC”)
|
||
Principal Amount:
|
$10.00 per unit
|
||
Term:
|
Approximately 14 months
|
||
Market Measure:
|
The SPDR® Gold Shares (Bloomberg symbol: “GLD”)
|
||
Starting Value:
|
The Closing Market Price of the Market Measure on the pricing date
|
||
Ending Value:
|
The average of the Closing Market Prices of the Market Measure times the Price Multiplier on each calculation day occurring during the Maturity Valuation Period. The scheduled calculation days are subject to
postponement in the event of Market Disruption Events, as described on page PS-24 of product supplement EQUITY ARN-1.
|
||
Price Multiplier:
|
1, subject to adjustment for certain events relating to the Market Measure, as described beginning on page PS-27 of product supplement EQUITY ARN-1.
|
||
Participation Rate:
|
300%
|
||
Capped Value:
|
[$11.525 to $11.925] per unit, which represents a return of [15.25% to 19.25%] over the principal amount. The actual Capped Value will be determined on the pricing date.
|
||
Maturity Valuation
Period:
|
Five scheduled calculation days shortly before the maturity date.
|
||
Fees and Charges:
|
The underwriting discount of $0.175 per unit listed on the cover page and the hedging related charge of $0.05 per unit described in “Structuring the Notes” below.
|
||
Calculation Agent:
|
BofA Securities, Inc. (“BofAS”).
|
◾ |
Product supplement EQUITY ARN-1 dated November 29, 2021:
|
◾ |
Series I MTN prospectus supplement dated September 14, 2021:
|
◾ |
Prospectus dated September 14, 2021:
|
◾ |
You anticipate that the Market Measure will increase moderately from the Starting Value to the Ending Value.
|
◾ |
You are willing to risk a loss of principal and return if the Market Measure decreases from the Starting Value to the Ending Value.
|
◾ |
You accept that the return on the notes will be capped.
|
◾ |
You are willing to forgo the interest payments that are paid on conventional interest bearing debt securities.
|
◾ |
You are willing to forgo the benefits of directly owning shares of the Underlying Fund or the commodity held by the Underlying Fund.
|
◾ |
You are willing to accept a limited or no market for sales prior to maturity, and understand that the market prices for the notes, if any, will be affected by various factors, including our actual and perceived creditworthiness,
our internal funding rate and fees and charges on the notes.
|
◾ |
You are willing to assume our credit risk, as issuer of the notes, for all payments under the notes, including the Redemption Amount.
|
◾ |
You believe that the Market Measure will decrease from the Starting Value to the Ending Value or that it will not increase sufficiently over the term of the notes to provide you with your desired return.
|
◾ |
You seek principal repayment or preservation of capital.
|
◾ |
You seek an uncapped return on your investment.
|
◾ |
You seek interest payments or other current income on your investment.
|
◾ |
You want to have the benefits of directly owning shares of the Underlying Fund or the commodity held by the Underlying Fund.
|
◾ |
You seek an investment for which there will be a liquid secondary market.
|
◾ |
You are unwilling or are unable to take market risk on the notes or to take our credit risk as issuer of the notes.
|
Ending Value
|
Percentage Change from the
Starting Value to the Ending
Value
|
Redemption Amount per
Unit
|
Total Rate of Return on the
Notes
|
|||
0.00
|
-100.00%
|
$0.00
|
-100.00%
|
|||
50.00
|
-50.00%
|
$5.00
|
-50.00%
|
|||
80.00
|
-20.00%
|
$8.00
|
-20.00%
|
|||
90.00
|
-10.00%
|
$9.00
|
-10.00%
|
|||
94.00
|
-6.00%
|
$9.40
|
-6.00%
|
|||
97.00
|
-3.00%
|
$9.70
|
-3.00%
|
|||
100.00(1)
|
0.00%
|
$10.00
|
0.00%
|
|||
102.00
|
2.00%
|
$10.60
|
6.00%
|
|||
103.00
|
3.00%
|
$10.90
|
9.00%
|
|||
105.75
|
5.75%
|
$11.725(2)
|
17.25%
|
|||
110.00
|
10.00%
|
$11.725
|
17.25%
|
|||
120.00
|
20.00%
|
$11.725
|
17.25%
|
|||
130.00
|
30.00%
|
$11.725
|
17.25%
|
|||
140.00
|
40.00%
|
$11.725
|
17.25%
|
|||
150.00
|
50.00%
|
$11.725
|
17.25%
|
|||
160.00
|
60.00%
|
$11.725
|
17.25%
|
(1) |
The hypothetical Starting Value of 100 used in these examples has been chosen for illustrative purposes only, and does not represent a likely actual Starting Value for the Market Measure.
|
(2) |
The Redemption Amount per unit cannot exceed the hypothetical Capped Value.
|
Example 1
|
|
The Ending Value is 80.00, or 80.00% of the Starting Value:
|
|
Starting Value:
|
100.00 |
Ending Value:
|
80.00 |
![]() |
= $8.00 Redemption Amount per unit
|
Example 2
|
|
The Ending Value is 103.00, or 103.00% of the Starting Value:
|
|
Starting Value:
|
100.00 |
Ending Value:
|
103.00 |
![]() |
= $10.90 Redemption Amount per unit
|
Example 3
|
|
The Ending Value is 130.00, or 130.00% of the Starting Value:
|
|
Starting Value:
|
100.00 |
Ending Value:
|
130.00 |
![]() |
= $19.00, however, because the Redemption Amount for the notes cannot exceed the Capped Value, the Redemption Amount will be $11.725 per unit
|
◾ |
Depending on the performance of the Market Measure as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal.
|
◾ |
Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity.
|
◾ |
Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. If we become insolvent or are unable to pay our obligations, you may lose your
entire investment.
|
◾ |
Your investment return is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the Market Measure or the commodity held by the Underlying Fund.
|
◾ |
The initial estimated value of the notes is an estimate only, determined as of a particular point in time by reference to our and our affiliates’ pricing models. These pricing models consider certain assumptions and variables,
including our credit spreads, our internal funding rate on the pricing date, mid-market terms on hedging transactions, expectations on interest rates and volatility, price-sensitivity analysis, and the expected term of the notes. These
pricing models rely in part on certain forecasts about future events, which may prove to be incorrect.
|
◾ |
The public offering price you pay for the notes will exceed the initial estimated value. If you attempt to sell the notes prior to maturity, their market value may be lower than the price you paid for them and lower than the initial
estimated value. This is due to, among other things, changes in the value of the Market Measure, our internal funding rate, and the inclusion in the public offering price of the underwriting discount and the hedging related charge, all as
further described in “Structuring the Notes” below. These factors, together with various credit, market and economic factors over the term of the notes, are expected to reduce the price at which you may be able to sell the notes in any
secondary market and will affect the value of the notes in complex and unpredictable ways.
|
◾ |
The initial estimated value does not represent a minimum or maximum price at which we, MLPF&S, BofAS or any of our affiliates would be willing to purchase your notes in any secondary market (if any exists) at any time. The value of
your notes at any time after issuance will vary based on many factors that cannot be predicted with accuracy, including the performance of the Market Measure, our creditworthiness and changes in market conditions.
|
◾ |
A trading market is not expected to develop for the notes. None of us, MLPF&S or BofAS is obligated to make a market for, or to repurchase, the notes. There is no assurance that any party will be willing to purchase your notes at
any price in any secondary market.
|
◾ |
Our business, hedging and trading activities, and those of MLPF&S, BofAS and our respective affiliates (including trades in shares of the Underlying Fund or the commodity held by the Underlying Fund), and any hedging and trading
activities we, MLPF&S, BofAS or our respective affiliates engage in for our clients’ accounts, may affect the market value and return of the notes and may create conflicts of interest with you.
|
◾ |
There may be potential conflicts of interest involving the calculation agent, which is BofAS. We have the right to appoint and remove the calculation agent.
|
◾ |
The sponsor and trustee of the Underlying Fund may adjust the Underlying Fund in a way that could adversely affect the value of the notes and the amount payable on the notes, and these entities have no obligation to consider your
interests.
|
◾ |
You will have no rights of a holder of the Underlying Fund or the commodity held by the Underlying Fund, and you will not be entitled to receive shares of the Underlying Fund or any of the gold held by the Underlying Fund.
|
◾ |
While we, MLPF&S, BofAS or our respective affiliates may from time to time own the Market Measure or the commodity held by the Underlying Fund, we, MLPF&S, BofAS and our respective affiliates do not control the Underlying Fund,
and have not verified any disclosure made by any other company.
|
◾ |
There are liquidity and management risks associated with the Underlying Fund.
|
◾ |
The performance of the Market Measure may not correlate with the performance of the commodity held by the Underlying Fund as well as the net asset value per share of the Underlying Fund, especially during periods of market volatility
when the
|
◾ |
If the liquidity of the commodity held by the Underlying Fund is limited, the value of the Market Measure and, therefore, the return on the notes would likely be impaired.
|
◾ |
Suspension or disruptions of market trading in the commodity held by the Underlying Fund may adversely affect the value of your notes.
|
◾ |
The notes will not be regulated by the U.S. Commodity Futures Trading Commission.
|
◾ |
The payments on the notes will not be adjusted for all corporate events that could affect the Underlying Fund. See “Description of ARNs—Anti Dilution and Discontinuance Adjustments Relating to Underlying Funds” in product supplement
EQUITY ARN-1.
|
◾ |
The U.S. federal income tax consequences of the notes are uncertain, and may be adverse to a holder of the notes. See “Summary of U.S. Federal Income Tax Consequences” below and “U.S. Federal Income Tax Summary” beginning on page
PS-39 of product supplement EQUITY ARN-1. For a discussion of the Canadian federal income tax consequences of investing in the notes, see “Tax Consequences—Canadian Taxation” in the prospectus dated September 14, 2021.
|
• |
the investor’s spouse (including a domestic partner), siblings, parents, grandparents, spouse’s parents, children and grandchildren, but excluding accounts held by aunts, uncles, cousins, nieces, nephews or
any other family relationship not directly above or below the individual investor;
|
• |
a family investment vehicle, including foundations, limited partnerships and personal holding companies, but only if the beneficial owners of the vehicle consist solely of the investor or members of the
investor’s household as described above; and
|
• |
a trust where the grantors and/or beneficiaries of the trust consist solely of the investor or members of the investor’s household as described above; provided that, purchases of the notes by a trust
generally cannot be aggregated together with any purchases made by a trustee’s personal account.
|
◾ |
There is no statutory, judicial, or administrative authority directly addressing the characterization of the notes.
|
◾ |
You agree with us (in the absence of a statutory, regulatory, administrative, or judicial ruling to the contrary) to characterize and treat the notes for all tax purposes as pre-paid cash-settled derivative contracts in respect of the
Underlying Fund.
|
◾ |
Under this characterization and tax treatment of the notes, a U.S. holder (as defined on page 42 of the prospectus) generally will recognize capital gain or loss upon the sale or maturity of the notes. This capital gain or loss
generally will be long-term capital gain or loss if you held the notes for more than one year.
|
◾ |
No assurance can be given that the Internal Revenue Service or any court will agree with this characterization and tax treatment.
|
◾ |
Under Section 1260 of the Code, “net underlying long-term capital gain“ on the notes may be subject to tax at higher rates applicable to “collectibles“ instead of the general rates that apply to long-term capital gain.
|
◾ |
Under current Internal Revenue Service guidance, withholding on “dividend equivalent” payments (as discussed in the product supplement), if any, will not apply to notes that are issued as of the date of this document unless such notes
are “delta-one” instruments. The discussion in the accompanying product supplement is modified to reflect Internal Revenue Service guidance, which states that the U.S. Treasury Department and the Internal Revenue Service intend to amend
the effective dates of the U.S. Treasury Department regulations to provide that withholding on dividend equivalent payments will not apply to specified equity-linked instruments that are not delta-one instruments and that are issued
before January 1, 2025.
|